HBV: Next Steps to a Cure

Volume 7, Issue 6

HBV: Next Steps to a Cure

In this issue:

Why has finding a cure for hepatitis B infection been so challenging? What is it about this virus and its life cycle that makes it so different from curable HCV? In this issue, Dr. Marion Peters from Northwestern University explains the obstacles researchers face in their quest to tame this virus.

Learning objective:

Describe the challenges researchers currently face in developing new hepatitis B treatments.

Author:

Marion Peters, MD

Adjunct Professor of Medicine
Northwestern University
Chicago, IL

Guest Faculty Disclosures

Dr. Peters has disclosed that she has served on the Advisory Boards of Atea, Aligos, Abbott, and Antios and that her spouse is an employee of Roche.

Unlabeled/Unapproved Uses

Dr. Peters has indicated that her presentation will not reference the unlabeled/unapproved uses of any drugs or products.

Program Directors:

Mark S. Sulkowski, MD

Professor of Medicine
Division of Infectious Diseases
Medical Director, Viral Hepatitis Center
Divisions of Infectious Diseases and Gastroenterology and Hepatology
Johns Hopkins School of Medicine
Baltimore, Maryland

Raymond T. Chung, MD

Director of Hepatology and Liver Center
Vice Chief, Gastroenterology
Kevin and Polly Maroni Research Scholar
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts

Taryn Haselhuhn, BA, BSN, MSN, CRNP

The Johns Hopkins Hospital
Baltimore, Maryland

Guest Faculty Disclosures:

Dr. Peters has disclosed that she has served on the Advisory Boards of Atea, Aligos, Abbott, and Antios and that her spouse is an employee of Roche.

Unlabeled/Unapproved Uses:

Dr. Peters has indicated that her presentation will not reference the unlabeled/unapproved uses of any drugs or products.

Length of activity:

0.5 hour Physicians
0.5 contact hour Nurses

Launch date: May 22, 2020
Expiration date: May 21, 2022

Start Issue